Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Paul Rutgeerts

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Procedures

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ferrante Marc; D'Haens Geert; Rutgeerts Paul; Vermeire Séverine; Van Assche Gert
Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).
D'Haens Geert; Rutgeerts Paul
Immunosuppression-associated lymphoma in IBD.
Karmiris Konstantinos; Paintaud Gilles; Noman Maja; Magdelaine-Beuzelin Charlotte; Ferrante Marc; Degenne Danielle; Claes Karolien; Coopman Tamara; Van Schuerbeek Nele; Van Assche Gert; Vermeire Severine; Rutgeerts Paul
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Paul Rutgeerts (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ferrante Marc; D'Haens Geert; Rutgeerts Paul; Vermeire Séverine; Van Assche Gert
Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Current gastroenterology reports 2009;11(6):504-8.
2009: D'Haens Geert; Rutgeerts Paul
Immunosuppression-associated lymphoma in IBD.
Lancet 2009;374(9701):1572-3.
2009: Karmiris Konstantinos; Paintaud Gilles; Noman Maja; Magdelaine-Beuzelin Charlotte; Ferrante Marc; Degenne Danielle; Claes Karolien; Coopman Tamara; Van Schuerbeek Nele; Van Assche Gert; Vermeire Severine; Rutgeerts Paul
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease.
Gastroenterology 2009;137(5):1628-40.
2009: Ruffolo C; Penninckx F; Van Assche G; Vermeire S; Rutgeerts P; Coremans G; D'Hoore A
Outcome of surgery for rectovaginal fistula due to Crohn's disease.
The British journal of surgery 2009;96(10):1190-5.
2009: Sandborn William J; Rutgeerts Paul; Feagan Brian G; Reinisch Walter; Olson Allan; Johanns Jewel; Lu Jiandong; Horgan Kevin; Rachmilewitz Daniel; Hanauer Stephen B; Lichtenstein Gary R; de Villiers Willem J S; Present Daniel; Sands Bruce E; Colombel Jean Frédéric
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Gastroenterology 2009;137(4):1250-60; quiz 1520.
2009: Henckaerts Liesbet; Van Steen Kristel; Verstreken Isabel; Cleynen Isabelle; Franke Andre; Schreiber Stefan; Rutgeerts Paul; Vermeire Séverine
Genetic risk profiling and prediction of disease course in Crohn's disease patients.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(9):972-980.e2.
2009: Schnitzler Fabian; Fidder Herma; Ferrante Marc; Noman Maja; Arijs Ingrid; Van Assche Gert; Hoffman Ilse; Van Steen Kristel; Vermeire Séverine; Rutgeerts Paul
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.
Inflammatory bowel diseases 2009;15(9):1295-301.
2009: Standaert-Vitse Annie; Sendid Boualem; Joossens Marie; François Nadine; Vandewalle-El Khoury Peggy; Branche Julien; Van Kruiningen Herbert; Jouault Thierry; Rutgeerts Paul; Gower-Rousseau Corinne; Libersa Christian; Neut Christel; Broly Franck; Chamaillard Mathias; Vermeire Séverine; Poulain Daniel; Colombel Jean-Frédéric
Candida albicans colonization and ASCA in familial Crohn's disease.
The American journal of gastroenterology 2009;104(7):1745-53.
2009: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Immunosuppression in inflammatory bowel disease: traditional, biological or both?
Current opinion in gastroenterology 2009;25(4):323-8.
2009: Colombel J-F; Schwartz D A; Sandborn W J; Kamm M A; D'Haens G; Rutgeerts P; Enns R; Panaccione R; Schreiber S; Li J; Kent J D; Lomax K G; Pollack P F
Adalimumab for the treatment of fistulas in patients with Crohn's disease.
Gut 2009;58(7):940-8.
2009: Ferrante M; D'Hoore A; Vermeire S; Declerck S; Noman M; Van Assche G; Hoffman I; Rutgeerts P; Penninckx F
Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis.
Inflammatory bowel diseases 2009;15(7):1062-70.
2009: Abreu Maria T; von Tirpitz Christian; Hardi Robert; Kaatz Martin; Van Assche Gert; Rutgeerts Paul; Bisaccia Emil; Goerdt Sergi; Hanauer Stephen; Knobler Robert; Mannon Peter; Mayer Lloyd; Ochsenkuhn Thomas; Sandborn William J; Parenti Dennis; Lee Kevin; Reinisch Walter;
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.
Inflammatory bowel diseases 2009;15(6):829-36.
2009: Colombel Jean-Frédéric; Sandborn William J; Rutgeerts Paul; Kamm Michael A; Yu Andrew P; Wu Eric Q; Pollack Paul F; Lomax Kathleen G; Chao Jingdong; Mulani Parvez M
Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
The American journal of gastroenterology 2009;104(5):1170-9.
2009: Magdelaine-Beuzelin Charlotte; Vermeire Séverine; Goodall Margaret; Baert Filip; Noman Maja; Assche Gert Van; Ohresser Marc; Degenne Danielle; Dugoujon Jean-Michel; Jefferis Roy; Rutgeerts Paul; Lefranc Maire-Paule; Watier Hervé
IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab.
Pharmacogenetics and genomics 2009;19(5):383-7.
2009: Bueno de Mesquita Mirjam; Ferrante Marc; Henckaerts Liesbet; Joossens Marie; Janssens Virginie; Hlavaty Tibor; Pierik Marie; Joossens Sofie; Van Schuerbeek Nele; Van Assche Gert; Rutgeerts Paul; Vermeire Severine; Hoffman Ilse
Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease.
European journal of pediatrics 2009;168(5):575-83.
2009: Rutgeerts Paul; Vermeire Severine; Van Assche Gert
Biological therapies for inflammatory bowel diseases.
Gastroenterology 2009;136(4):1182-97.
2009: Fidder H; Schnitzler F; Ferrante M; Noman M; Katsanos K; Segaert S; Henckaerts L; Van Assche G; Vermeire S; Rutgeerts P
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study.
Gut 2009;58(4):501-8.
2009: Schnitzler F; Fidder H; Ferrante M; Noman M; Arijs I; Van Assche G; Hoffman I; Van Steen K; Vermeire S; Rutgeerts P
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
Gut 2009;58(4):492-500.
2009: Vermeire Severine; Van Assche Gert; Rutgeerts Paul
Genetic analysis to predict prognosis at the onset of Crohn's disease: not yet ready for prime time?
Gut 2009;58(3):323-4.
2009: Weersma Rinse K; Stokkers Pieter C F; Cleynen Isabelle; Wolfkamp Simone C S; Henckaerts Liesbet; Schreiber Stefan; Dijkstra Gerard; Franke Andre; Nolte Ilja M; Rutgeerts Paul; Wijmenga Cisca; Vermeire Séverine
Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.
The American journal of gastroenterology 2009;104(3):630-8.
2009: De Preter Vicky; Bulteel Veerle; Suenaert Peter; Geboes Karen Paula; De Hertogh Gert; Luypaerts Anja; Geboes Karel; Verbeke Kristin; Rutgeerts Paul
Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa.
Inflammatory bowel diseases 2009;15(3):335-40.
2009: De Preter Vicky; Van Staeyen Greet; Esser Diederik; Rutgeerts Paul; Verbeke Kristin
Development of a screening method to determine the pattern of fermentation metabolites in faecal samples using on-line purge-and-trap gas chromatographic-mass spectrometric analysis.
Journal of chromatography. A 2009;1216(9):1476-83.
2009: Villani Alexandra-Chloé; Lemire Mathieu; Fortin Geneviève; Louis Edouard; Silverberg Mark S; Collette Catherine; Baba Nobuyasu; Libioulle Cécile; Belaiche Jacques; Bitton Alain; Gaudet Daniel; Cohen Albert; Langelier Diane; Fortin Paul R; Wither Joan E; Sarfati Marika; Rutgeerts Paul; Rioux John D; Vermeire Severine; Hudson Thomas J; Franchimont Denis
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility.
Nature genetics 2009;41(1):71-6.
2009: Henckaerts Liesbet; Nielsen Kaspar R; Steffensen Rudi; Van Steen Kristel; Mathieu Chantal; Giulietti Annapaula; Wouters Pieter J; Milants Ilse; Vanhorebeek Ilse; Langouche Lies; Vermeire Séverine; Rutgeerts Paul; Thiel Steffen; Wilmer Alexander; Hansen Troels Krarup; Van den Berghe Greet
Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit.
Critical care medicine 2009;37(1):192-201, e1-3.
2009: Henckaerts Liesbet; Jaspers Martine; Van Steenbergen Werner; Vliegen Liesbet; Fevery Johan; Nuytten Hilde; Roskams Tania; Rutgeerts Paul; Cassiman Jean-Jacques; Vermeire Séverine; Cuppens Harry
Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
Journal of hepatology 2009;50(1):150-7.
2009: Villani Alexandra-Chloé; Lemire Mathieu; Louis Edouard; Silverberg Mark S; Collette Catherine; Fortin Geneviève; Nimmo Elaine R; Renaud Yannick; Brunet Sébastien; Libioulle Cécile; Belaiche Jacques; Bitton Alain; Gaudet Daniel; Cohen Albert; Langelier Diane; Rioux John D; Arnott Ian D R; Wild Gary E; Rutgeerts Paul; Satsangi Jack; Vermeire Séverine; Hudson Thomas J; Franchimont Denis
Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.
PloS one 2009;4(9):e7154.
2009: Vermeire Séverine; Van Assche Gert; Rutgeerts Paul
Serum sickness, encephalitis and other complications of anti-cytokine therapy.
Best practice & research. Clinical gastroenterology 2009;23(1):101-12.
2009: Koslowski Maureen J; Kübler Irmgard; Chamaillard Mathias; Schaeffeler Elke; Reinisch Walter; Wang Guoxing; Beisner Julia; Teml Alexander; Peyrin-Biroulet Laurent; Winter Stefan; Herrlinger Klaus R; Rutgeerts Paul; Vermeire Séverine; Cooney Rachel; Fellermann Klaus; Jewell Derek; Bevins Charles L; Schwab Matthias; Stange Eduard F; Wehkamp Jan
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
PloS one 2009;4(2):e4496.
2008: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Optimizing treatment of inflammatory bowel diseases with biologic agents.
Current gastroenterology reports 2008;10(6):591-6.
2008: Franke Andre; Balschun Tobias; Karlsen Tom H; Sventoraityte Jurgita; Nikolaus Susanna; Mayr Gabriele; Domingues Francisco S; Albrecht Mario; Nothnagel Michael; Ellinghaus David; Sina Christian; Onnie Clive M; Weersma Rinse K; Stokkers Pieter C F; Wijmenga Cisca; Gazouli Maria; Strachan David; McArdle Wendy L; Vermeire Séverine; Rutgeerts Paul; Rosenstiel Philip; Krawczak Michael; Vatn Morten H; Mathew Christopher G; Schreiber Stefan
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.
Nature genetics 2008;40(11):1319-23.
2008: Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Acta gastro-enterologica Belgica 2008;71(4):367-72.
2008: D'Haens Geert R; Vermeire Severine; Van Assche Gert; Noman Maja; Aerden Isolde; Van Olmen Gust; Rutgeerts Paul
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.
Gastroenterology 2008;135(4):1123-9.
2008: Sandborn William J; Feagan Brian G; Fedorak Richard N; Scherl Ellen; Fleisher Mark R; Katz Seymour; Johanns Jewel; Blank Marion; Rutgeerts Paul;
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
Gastroenterology 2008;135(4):1130-41.
2008: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Treatment of severe steroid refractory ulcerative colitis.
World journal of gastroenterology : WJG 2008;14(36):5508-11.
2008: Burke John P; Ferrante Marc; Dejaegher Karen; Watson R William G; Docherty Neil G; De Hertogh Gert; Vermeire Severine; Rutgeerts Paul; D'Hoore Andre; Penninckx Freddy; Geboes Karel; Van Assche Gert; O'Connell P Ronan
Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease.
Inflammatory bowel diseases 2008;14(9):1197-204.
2008: Cloetens Lieselotte; De Preter Vicky; Swennen Katrien; Broekaert Willem F; Courtin Christophe M; Delcour Jan A; Rutgeerts Paul; Verbeke Kristin
Dose-response effect of arabinoxylooligosaccharides on gastrointestinal motility and on colonic bacterial metabolism in healthy volunteers.
Journal of the American College of Nutrition 2008;27(4):512-8.
2008: Hoffman I; Vermeire S; Van Assche G; Rutgeerts P
Infliximab for pediatric Crohn's disease.
Drugs of today (Barcelona, Spain : 1998) 2008;44(8):615-28.
2008: Cloetens Lieselotte; De Preter Vicky; De Loor Henriette; Rutgeerts Paul; Verbeke Kristin
Does the biomarker 15N-lactose ureide allow to estimate the site of fermentation of resistant starch?
European journal of nutrition 2008;47(4):217-23.
2008: Vermeire Severine; Vermeulen Nathalie; Van Assche Gert; Bossuyt Xavier; Rutgeerts Paul
(Auto)antibodies in inflammatory bowel diseases.
Gastroenterology clinics of North America 2008;37(2):429-38, vii.
2008: Van Assche Gert; Magdelaine-Beuzelin Charlotte; D'Haens Geert; Baert Filip; Noman Maja; Vermeire Séverine; Ternant David; Watier Hervé; Paintaud Gilles; Rutgeerts Paul
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.
Gastroenterology 2008;134(7):1861-8.
2008: Feagan Brian G; Sandborn William J; Mittmann Ulrich; Bar-Meir Simon; D'Haens Geert; Bradette Marc; Cohen Albert; Dallaire Chrystian; Ponich Terry P; McDonald John W D; Hébuterne Xavier; Paré Pierre; Klvana Pavel; Niv Yaron; Ardizzone Sandro; Alexeeva Olga; Rostom Alaa; Kiudelis Gediminas; Spleiss Johannes; Gilgen Denise; Vandervoort Margaret K; Wong Cindy J; Zou Guang Yong; Donner Allan; Rutgeerts Paul
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.
JAMA : the journal of the American Medical Association 2008;299(14):1690-7.
2008: Vandewalle-El Khoury Peggy; Colombel Jean-Frederic; Joossens Sofie; Standaert-Vitse Annie; Collot Mayeul; Halfvarson Jonas; Ayadi Ali; Landers Carol J; Vermeire Severine; Rutgeerts Paul; Targan Stephan R; Chamaillard Mathias; Mallet Jean-Maurice; Sendid Boualem; Poulain Daniel
Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
The American journal of gastroenterology 2008;103(4):949-57.
2008: Vermeulen Nathalie; Arijs Ingrid; Joossens Sofie; Vermeire Severine; Clerens Stefan; Van den Bergh Karolien; Michiels Georges; Arckens Lutgarde; Schuit Frans; Van Lommel Leentje; Rutgeerts Paul; Bossuyt Xavier
Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.
Clinical chemistry 2008;54(3):534-41.
2008: de Preter V; Vanhoutte T; Huys G; Swings J; Rutgeerts P; Verbeke K
Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects.
Alimentary pharmacology & therapeutics 2008;27(6):504-13.
2008: Rutgeerts Paul; Schreiber Stefan; Feagan Brian; Keininger Dorothy L; O'Neil Liz; Fedorak Richard N;
Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease.
International journal of colorectal disease 2008;23(3):289-96.
2008: D'Haens Geert; Baert Filip; van Assche Gert; Caenepeel Philip; Vergauwe Philippe; Tuynman Hans; De Vos Martine; van Deventer Sander; Stitt Larry; Donner Allan; Vermeire Severine; Van de Mierop Frank J; Coche Jean-Charles R; van der Woude Janneke; Ochsenkühn Thomas; van Bodegraven Ad A; Van Hootegem Philippe P; Lambrecht Guy L; Mana Fazia; Rutgeerts Paul; Feagan Brian G; Hommes Daniel;
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
Lancet 2008;371(9613):660-7.
2008: De Preter V; Raemen H; Cloetens L; Houben E; Rutgeerts P; Verbeke K
Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities.
European journal of clinical nutrition 2008;62(2):225-31.
2008: Ferrante Marc; Declerck Sarah; De Hertogh Gert; Van Assche Gert; Geboes Karel; Rutgeerts Paul; Penninckx Freddy; Vermeire Séverine; D'Hoore Andre
Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
Inflammatory bowel diseases 2008;14(1):20-8.
2008: Peeters Harald; Vander Cruyssen Bert; Mielants Herman; de Vlam Kurt; Vermeire Séverine; Louis Edouard; Rutgeerts Paul; Belaiche Jacques; De Vos Martine
Clinical and genetic factors associated with sacroiliitis in Crohn's disease.
Journal of gastroenterology and hepatology 2008;23(1):132-7.
2007: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Adalimumab in Crohn's disease.
Biologics : targets & therapy 2007;1(4):355-65.
2007: Dideberg Vinciane; Kristjansdottir Gudlaug; Milani Lili; Libioulle Cécile; Sigurdsson Snaevar; Louis Edouard; Wiman Ann-Christin; Vermeire Séverine; Rutgeerts Paul; Belaiche Jacques; Franchimont Denis; Van Gossum André; Bours Vincent; Syvänen Ann-Christine
An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
Human molecular genetics 2007;16(24):3008-16.
2007: Henckaerts Liesbet; Pierik Marie; Joossens Marie; Ferrante Marc; Rutgeerts Paul; Vermeire Séverine
Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
Gut 2007;56(11):1536-42.
2007: De Peter Vicky; Cloetens Lieselotte; Rutgeerts Paul; Verbeke Kristin
Influence of resistant starch alone or combined with wheat bran on gastric emptying and protein digestion in healthy volunteers.
Scandinavian journal of gastroenterology 2007;42(10):1187-93.
2007: Ferrante Marc; Henckaerts Liesbet; Joossens Marie; Pierik Marie; Joossens Sofie; Dotan Nir; Norman Gary L; Altstock Rom T; Van Steen Kristel; Rutgeerts Paul; Van Assche Gert; Vermeire Séverine
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
Gut 2007;56(10):1394-403.
2007: Reinisch Walter; Sandborn William J; Bala Mohan; Yan Songkai; Feagan Brian G; Rutgeerts Paul; Radford-Smith Graham; Xu Stephen; Eisenberg Debra; Olson Allan; Colombel Jean Frédéric
Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis.
Inflammatory bowel diseases 2007;13(9):1135-40.
2007: Arts J; Sifrim D; Rutgeerts P; Lerut A; Janssens J; Tack J
Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease.
Digestive diseases and sciences 2007;52(9):2170-7.
2007: Sandborn W J; Hanauer S B; Rutgeerts P; Fedorak R N; Lukas M; MacIntosh D G; Panaccione R; Wolf D; Kent J D; Bittle B; Li J; Pollack P F
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Gut 2007;56(9):1232-9.
2007: Vermeire Severine; Noman Maja; Van Assche Gert; Baert Filip; D'Haens Geert; Rutgeerts Paul
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease.
Gut 2007;56(9):1226-31.
2007: Sandborn William J; Feagan Brian G; Stoinov Simeon; Honiball Pieter J; Rutgeerts Paul; Mason David; Bloomfield Ralph; Schreiber Stefan;
Certolizumab pegol for the treatment of Crohn's disease.
The New England journal of medicine 2007;357(3):228-38.
2007: Clark Michael; Colombel Jean-Frederic; Feagan Brian C; Fedorak Richard N; Hanauer Stephen B; Kamm Michael A; Mayer Lloyd; Regueiro Carol; Rutgeerts Paul; Sandborn William J; Sands Bruce E; Schreiber Stefan; Targan Stephan; Travis Simon; Vermeire Severine
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
Gastroenterology 2007;133(1):312-39.
2007: Van Kruiningen Herbert J; Joossens Marie; Vermeire Severine; Joossens Sofie; Debeugny Stéphane; Gower-Rousseau Corinne; Cortot Antoine; Colombel Jean-Frédéric; Rutgeerts Paul; Vlietinck Robert
Familial Crohn's disease in Belgium: pedigrees, temporal relationships among cases, and family histories.
Journal of clinical gastroenterology 2007;41(6):583-90.
2007: Henckaerts Liesbet; Fevery Johan; Van Steenbergen Werner; Verslype Chris; Nevens Frederik; Yap Paul; Roskams Tania; Rutgeerts Paul; Vermeire Severine
The RANTES -28 g polymorphism is associated with primary sclerosing cholangitis.
Gut 2007;56(6):891-2.
2007: Sandborn William J; Rutgeerts Paul; Enns Robert; Hanauer Stephen B; Colombel Jean-Frédéric; Panaccione Remo; D'Haens Geert; Li Ju; Rosenfeld Marie R; Kent Jeffrey D; Pollack Paul F
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
Annals of internal medicine 2007;146(12):829-38.
2007: Joossens Marie; Simoens Marc; Vermeire Séverine; Bossuyt Xavier; Geboes Karel; Rutgeerts Paul
Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases.
Inflammatory bowel diseases 2007;13(5):580-4.
2007: Libioulle Cécile; Louis Edouard; Hansoul Sarah; Sandor Cynthia; Farnir Frédéric; Franchimont Denis; Vermeire Séverine; Dewit Olivier; de Vos Martine; Dixon Anna; Demarche Bruno; Gut Ivo; Heath Simon; Foglio Mario; Liang Liming; Laukens Debby; Mni Myriam; Zelenika Diana; Van Gossum André; Rutgeerts Paul; Belaiche Jacques; Lathrop Mark; Georges Michel
Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4.
PLoS genetics 2007;3(4):e58.
2007: Rutgeerts Paul; Vermeire Severine; Van Assche Gert
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
Gut 2007;56(4):453-5.
2007: Feagan Brian G; Reinisch Walter; Rutgeerts Paul; Sandborn William J; Yan Songkai; Eisenberg Debra; Bala Mohan; Johanns Jewel; Olson Allan; Hanauer Stephen B
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
The American journal of gastroenterology 2007;102(4):794-802.
2007: Hlavaty Tibor; Ferrante Marc; Henckaerts Liesbet; Pierik Marie; Rutgeerts Paul; Vermeire Severine
Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors.
Inflammatory bowel diseases 2007;13(4):372-9.
2007: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Endoscopic therapy of strictures in Crohn's disease.
Inflammatory bowel diseases 2007;13(3):356-8; discussion 362-3.
2007: Shen Chong; de Hertogh Gert; Bullens Dominique M A; Van Assche Gert; Geboes Karel; Rutgeerts Paul; Ceuppens Jan L
Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization?
Inflammatory bowel diseases 2007;13(3):308-16.
2007: D'Haens Geert; Sandborn William J; Feagan Brian G; Geboes Karel; Hanauer Stephen B; Irvine E Jan; Lémann Marc; Marteau Philippe; Rutgeerts Paul; Schölmerich Jurgen; Sutherland Lloyd R
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
Gastroenterology 2007;132(2):763-86.
2007: Ferrante Marc; Vermeire Séverine; Katsanos Konstantinos H; Noman Maja; Van Assche Gert; Schnitzler Fabian; Arijs Ingrid; De Hertogh Gert; Hoffman Ilse; Geboes J Karel; Rutgeerts Paul
Predictors of early response to infliximab in patients with ulcerative colitis.
Inflammatory bowel diseases 2007;13(2):123-8.
2007: Colombel Jean-Frédéric; Sandborn William J; Rutgeerts Paul; Enns Robert; Hanauer Stephen B; Panaccione Remo; Schreiber Stefan; Byczkowski Dan; Li Ju; Kent Jeffrey D; Pollack Paul F
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Gastroenterology 2007;132(1):52-65.
2007: Shen Chong; Dillissen Ellen; Kasran Ahmad; Lin Yuan; Herman Jean; Sienaert Ilse; De Jonghe Steven; Kerremans Luk; Geboes Karel; Boon Louis; Rutgeerts Paul; Ceuppens Jan L
Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in mice.
Clinical immunology (Orlando, Fla.) 2007;122(1):53-61.
2007: De Preter Vicky; Vanhoutte Tom; Huys Geert; Swings Jean; De Vuyst Luc; Rutgeerts Paul; Verbeke Kristin
Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans.
American journal of physiology. Gastrointestinal and liver physiology 2007;292(1):G358-68.
2007: Lebeer S; Ceuppens J; Geboes K; Van Assche G; Rutgeerts P; Vanderleyden J; De Keersmaecker S
Mechanisms of probiotic-host interaction with IBD as a case study: a role for exopolysaccharides?
Communications in agricultural and applied biological sciences 2007;72(1):41-5.
2006: De Preter Vicky; Coopmans Tamara; Rutgeerts Paul; Verbeke Kristin
Influence of long-term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjects.
Journal of the American College of Nutrition 2006;25(6):541-9.
2006: Geboes Karen P; De Hertogh Gert; De Preter Vicky; Luypaerts Anja; Bammens Bert; Evenepoel Pieter; Ghoos Yvo; Geboes Karel; Rutgeerts Paul; Verbeke Kristin
The influence of inulin on the absorption of nitrogen and the production of metabolites of protein fermentation in the colon.
The British journal of nutrition 2006;96(6):1078-86.
2006: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapies.
Gastroenterology clinics of North America 2006;35(4):743-56.
2006: Van Assche G; Sandborn W J; Feagan B G; Salzberg B A; Silvers D; Monroe P S; Pandak W M; Anderson F H; Valentine J F; Wild G E; Geenen D J; Sprague R; Targan S R; Rutgeerts P; Vexler V; Young D; Shames R S
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial.
Gut 2006;55(11):1568-74.
2006: Ferrante Marc; Penninckx Freddy; De Hertogh Gert; Geboes Karel; D'Hoore Andre; Noman Maja; Vermeire Séverine; Rutgeerts Paul; Van Assche Gert
Protein-losing enteropathy in Crohn's disease.
Acta gastro-enterologica Belgica 2006;69(4):384-9.
2006: Dideberg Vinciane; Théâtre Emilie; Farnir Frédéric; Vermeire Séverine; Rutgeerts Paul; De Vos Martine; Belaiche Jacques; Franchimont Denis; Van Gossum André; Louis Edouard; Bours Vincent
The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease.
Pharmacogenetics and genomics 2006;16(10):727-34.
2006: Rutgeerts P
Review article: recurrence of Crohn's disease after surgery - the need for treatment of new lesions.
Alimentary pharmacology & therapeutics 2006;24 Suppl 3():29-32.
2006: Ferrante Marc; Pierik Marie; Henckaerts Liesbet; Joossens Marie; Claes Karolien; Van Schuerbeek Nele; Vlietinck Robert; Rutgeerts Paul; Van Assche Gert; Vermeire Severine
The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease.
Inflammatory bowel diseases 2006;12(9):870-8.
2006: Holtmann Martin H; Krummenauer Frank; Claas Christina; Kremeyer Kristina; Lorenz Dirk; Rainer Olivia; Vogel Iris; Böcker Ulrich; Böhm Stephan; Büning Carsten; Duchmann Rainer; Gerken Guido; Herfarth Hans; Lügering Norbert; Kruis Wolfgang; Reinshagen Max; Schmidt Jan; Stallmach Andreas; Stein Jürgen; Sturm Andreas; Galle Peter R; Hommes Daan W; D'Haens Geert; Rutgeerts Paul; Neurath Markus F
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.
Digestive diseases and sciences 2006;51(9):1516-24.
2006: Shen Chong; Dillissen Ellen; Kasran Ahmad; Lin Yuan; Clydesdale Gavin; Sienaert Ilse; Jonghe Steven De; Gao Ling-Jie; Geboes Karel; Boon Louis; Rutgeerts Paul; Ceuppens Jan L
Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(8):575-82.
2006: Cukovic-Cavka Silvija; Vermeire Severine; Hrstic Irena; Claessens Greet; Kolacek Sanja; Jakic-Razumovic Jasminka; Krznaric Zeljko; Grubelic Katja; Radic Davor; Misak Zrinjka; Jadresin Oleg; Rutgeerts Paul; Vucelic Boris
NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.
European journal of gastroenterology & hepatology 2006;18(8):895-9.
2006: De Hertogh G; Aerssens J; de Hoogt R; Peeters P; Verhasselt P; Van Eyken P; Ectors N; Vermeire S; Rutgeerts P; Coulie B; Geboes K
Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity.
The Journal of pathology 2006;209(4):532-9.
2006: Rutgeerts Paul; Sandborn William J; Fedorak Richard N; Rachmilewitz Daniel; Tarabar Dino; Gibson Peter; Haagen Nielsen Ole; Wild Gary; Schreiber Stefan; Pena Rossi Claudia; Zignani Monia;
Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(7):888-93.
2006: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Safety issues with biological therapies for inflammatory bowel disease.
Current opinion in gastroenterology 2006;22(4):370-6.
2006: Pierik Marie; Rutgeerts Paul; Vlietinck Robert; Vermeire Severine
Pharmacogenetics in inflammatory bowel disease.
World journal of gastroenterology : WJG 2006;12(23):3657-67.
2006: Moskovitz David N; Van Assche Gert; Maenhout Benedikte; Arts Joris; Ferrante Marc; Vermeire Severine; Rutgeerts Paul
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(6):760-5.
2006: Ferrante Marc; de Hertogh Gert; Hlavaty Tibor; D'Haens Geert; Penninckx Freddy; D'Hoore Andre; Vermeire Séverine; Rutgeerts Paul; Geboes Karel; van Assche Gert
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence.
Gastroenterology 2006;130(6):1595-606.
2006: Lakatos Peter Laszlo; Fischer Simon; Claes Karolien; Kovacs Agota; Molnar Tamas; Altorjay Istvan; Demeter Pal; Tulassay Zsolt; Palatka Karoly; Papp Maria; Rutgeerts Paul; Szalay Ferenc; Papp Janos; Vermeire Severine; Lakatos Laszlo;
DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.
Inflammatory bowel diseases 2006;12(5):362-8.
2006: Dideberg Vinciane; Louis Edouard; Farnir Frédéric; Bertoli Sabrina; Vermeire Séverine; Rutgeerts Paul; De Vos Martine; Van Gossum André; Belaiche Jacques; Bours Vincent
Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study.
Pharmacogenetics and genomics 2006;16(5):369-73.
2006: Joossens S; Pierik M; Rector A; Vermeire S; Ranst M V; Rutgeerts P; Bossuyt X
Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease.
Gut 2006;55(5):746.
2006: Stas P; D'Hoore A; Van Assche G; Geboes K; Steenkiste E; Penninckx F; Rutgeerts P; Vermeire S
Miliary tuberculosis following infliximab therapy for Crohn disease: A case report and review of the literature.
Acta gastro-enterologica Belgica 2006;69(2):217-20.
2006: Henckaerts Liesbet; Fevery Johan; Van Steenbergen Werner; Verslype Chris; Yap Paul; Nevens Frederik; Roskams Tania; Libbrecht Louis; Rutgeerts Paul; Vermeire Séverine
CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis.
Inflammatory bowel diseases 2006;12(4):272-7.
2006: De Preter V; Vanhoutte T; Huys G; Swings J; Rutgeerts P; Verbeke K
Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects.
Alimentary pharmacology & therapeutics 2006;23(7):963-74.
2006: Vermeire S; Rutgeerts P
The changing face of treatment for Crohn's disease.
The British journal of surgery 2006;93(4):385-6.
2006: Hlavaty Tibor; Persoons Philippe; Vermeire Severine; Ferrante Marc; Pierik Marie; Van Assche Gert; Rutgeerts Paul
Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease.
Inflammatory bowel diseases 2006;12(3):199-204.
2006: Rutgeerts Paul; Diamond Robert H; Bala Mohan; Olson Allan; Lichtenstein Gary R; Bao Weihang; Patel Kamlesh; Wolf Douglas C; Safdi Michael; Colombel Jean Frederic; Lashner Bret; Hanauer Stephen B
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Gastrointestinal endoscopy 2006;63(3):433-42; quiz 464.
2006: Vermeire S; Van Assche G; Rutgeerts P
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Gut 2006;55(3):426-31.
2006: Hanauer Stephen B; Sandborn William J; Rutgeerts Paul; Fedorak Richard N; Lukas Milan; MacIntosh Donald; Panaccione Remo; Wolf Douglas; Pollack Paul
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Gastroenterology 2006;130(2):323-33; quiz 591.
2006: Rutgeerts P; Van Assche G; Vermeire S
Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
Alimentary pharmacology & therapeutics 2006;23(4):451-63.
2006: Maerten P; Kwon B S; Shen C; De Hertogh G; Cadot P; Bullens D M A; Overbergh L; Mathieu C; Van Assche G; Geboes K; Rutgeerts P; Ceuppens J L
Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis.
Clinical and experimental immunology 2006;143(2):228-36.
2006: Shen Chong; Van Assche Gert; Rutgeerts Paul; Ceuppens Jan L
Caspase activation and apoptosis induction by adalimumab: demonstration in vitro and in vivo in a chimeric mouse model.
Inflammatory bowel diseases 2006;12(1):22-8.
2006: Pierik Marie; Joossens Sofie; Van Steen Kristel; Van Schuerbeek Nele; Vlietinck Robert; Rutgeerts Paul; Vermeire Severine
Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases.
Inflammatory bowel diseases 2006;12(1):1-8.
2006: Willot Stéphanie; Vermeire Severine; Ohresser Marc; Rutgeerts Paul; Paintaud Gilles; Belaiche Jacques; De Vos Martine; Van Gossum André; Franchimont Denis; Colombel Jean-Fréderic; Watier Hervé; Louis Edouard
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease.
Pharmacogenetics and genomics 2006;16(1):37-42.
2006: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Emerging biological treatments in inflammatory bowel diseases.
Digestive diseases (Basel, Switzerland) 2006;24(1-2):131-6.
2005: Preda Carmen Monica; Vermeire Severine; Rutgeerts Paul; Joosens Sophie; Diculescu Mircea; Marica Catalina; Ciocarlan Mihai; Mirea Virginia; Oproiu Alexandru
Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.
Romanian journal of gastroenterology 2005;14(4):357-60.
2005: Vermeire Séverine; Pierik Marie; Hlavaty Tibor; Claessens Greet; van Schuerbeeck Nele; Joossens Sofie; Ferrante Marc; Henckaerts Liesbet; Bueno de Mesquita Mirjam; Vlietinck Robert; Rutgeerts Paul
Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
Gastroenterology 2005;129(6):1845-53.
2005: Rutgeerts Paul; Sandborn William J; Feagan Brian G; Reinisch Walter; Olson Allan; Johanns Jewel; Travers Suzanne; Rachmilewitz Daniel; Hanauer Stephen B; Lichtenstein Gary R; de Villiers Willem J S; Present Daniel; Sands Bruce E; Colombel Jean Frédéric
Infliximab for induction and maintenance therapy for ulcerative colitis.
The New England journal of medicine 2005;353(23):2462-76.
2005: Vermeire Séverine; Van Assche Gert; Rutgeerts Paul
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases.
Nature clinical practice. Gastroenterology & hepatology 2005;2(12):580-6.
2005: Geboes Karel; Rutgeerts Paul; Opdenakker Ghislain; Olson Allan; Patel Kamlesh; Wagner Carrie L; Marano Colleen W
Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
Current medical research and opinion 2005;21(11):1741-54.
2005: Sandborn William J; Colombel Jean Frédéric; Enns Roberts; Feagan Brian G; Hanauer Stephen B; Lawrance Ian C; Panaccione Remo; Sanders Martin; Schreiber Stefan; Targan Stephan; van Deventer Sander; Goldblum Ronald; Despain Darrin; Hogge Gary S; Rutgeerts Paul;
Natalizumab induction and maintenance therapy for Crohn's disease.
The New England journal of medicine 2005;353(18):1912-25.
2005: Hlavaty T; Pierik M; Henckaerts L; Ferrante M; Joossens S; van Schuerbeek N; Noman M; Rutgeerts P; Vermeire S
Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
Alimentary pharmacology & therapeutics 2005;22(7):613-26.
2005: Schreiber Stefan; Rutgeerts Paul; Fedorak Richard N; Khaliq-Kareemi Munaa; Kamm Michael A; Boivin Michel; Bernstein Charles N; Staun Michael; Thomsen Ole Østergaard; Innes Alison;
A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease.
Gastroenterology 2005;129(3):807-18.
2005: Joossens S; Suenaert P; Noman M; Vermeire S; Rutgeerts P
Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability.
Inflammatory bowel diseases 2005;11(9):863-4.
2005: Maerten Philippe; Shen Chong; Bullens Dominique M A; Van Assche Gert; Van Gool Stefaan; Geboes Karel; Rutgeerts Paul; Ceuppens Jan L
Effects of interleukin 4 on CD25+CD4+ regulatory T cell function.
Journal of autoimmunity 2005;25(2):112-20.
2005: Kasran A; Boon L; Wortel C H; Hogezand R A; Schreiber S; Goldin E; Boer M; Geboes K; Rutgeerts P; Ceuppens J L
Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease.
Alimentary pharmacology & therapeutics 2005;22(2):111-22.
2005: Persoons P; Vermeire S; Demyttenaere K; Fischler B; Vandenberghe J; Van Oudenhove L; Pierik M; Hlavaty T; Van Assche G; Noman M; Rutgeerts P
The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
Alimentary pharmacology & therapeutics 2005;22(2):101-10.
2005: Suenaert Peter; Bulteel Veerle; Vermeire Severine; Noman Maja; Van Assche Gert; Rutgeerts Paul
Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent.
Inflammatory bowel diseases 2005;11(7):667-73.
2005: Van Assche Gert; Van Ranst Marc; Sciot Raf; Dubois Bénédicte; Vermeire Séverine; Noman Maja; Verbeeck Jannick; Geboes Karel; Robberecht Wim; Rutgeerts Paul
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
The New England journal of medicine 2005;353(4):362-8.
2005: Van Assche Gert; Vermeire Séverine; Rutgeerts Paul
Medical treatment of inflammatory bowel diseases.
Current opinion in gastroenterology 2005;21(4):443-7.
2005: Van Ranst Marc; Joossens Marie; Joossens Sofie; Van Steen Kristel; Pierik Marieke; Vermeire Severine; Rutgeerts Paul
Crohn's disease and month of birth.
Inflammatory bowel diseases 2005;11(6):597-9.
2005: Shen Chong; Maerten Philippe; Geboes Karel; Van Assche Gert; Rutgeerts Paul; Ceuppens Jan L
Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model.
Clinical immunology (Orlando, Fla.) 2005;115(3):250-9.
2005: Lemahieu Wim; Maes Bart; Verbeke Kristin; Rutgeerts Paul; Geboes Karel; Vanrenterghem Yves
Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(6):1383-91.
2005: Geboes Karen P; De Preter Vicky; Luypaerts Anja; Bammens Bert; Evenepoel Pieter; Ghoos Yvo; Rutgeerts Paul; Verbeke Kristin
Validation of lactose[15N,15N]ureide as a tool to study colonic nitrogen metabolism.
American journal of physiology. Gastrointestinal and liver physiology 2005;288(5):G994-9.
2005: Rutgeerts Paul; Van Assche Gert; Vermeire Séverine; D'Haens Geert; Baert Filip; Noman Maja; Aerden Isolde; De Hertogh Gert; Geboes Karel; Hiele Martin; D'Hoore Andre; Penninckx Freddy
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.
Gastroenterology 2005;128(4):856-61.
2005: Van Kruiningen Herbert J; Joossens Marie; Vermeire Severine; Joossens Sofie; Debeugny Stéphane; Gower-Rousseau Corinne; Cortot Antoine; Colombel Jean-Frédéric; Rutgeerts Paul; Vlietinck Robert
Environmental factors in familial Crohn's disease in Belgium.
Inflammatory bowel diseases 2005;11(4):360-5.
2005: Preda Carmen Monica; Diculescu Mircea; Mirea Virginia; Marica Catalin; Vermeire Severine; Rutgeerts Paul; Oproiu Alexandru
Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
Romanian journal of gastroenterology 2005;14(1):23-6.
2005: Arts J; Lerut T; Rutgeerts P; Sifrim D; Janssens J; Tack J
A one-year follow-up study of endoluminal gastroplication (Endocinch) in GERD patients refractory to proton pump inhibitor therapy.
Digestive diseases and sciences 2005;50(2):351-6.
2005: Shen C; Assche G V; Colpaert S; Maerten P; Geboes K; Rutgeerts P; Ceuppens J L
Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept.
Alimentary pharmacology & therapeutics 2005;21(3):251-8.
2005: Van Assche Gert; Rutgeerts Paul
Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.
American journal of physiology. Gastrointestinal and liver physiology 2005;288(2):G169-74.
2005: Pierik M; De Hertogh G; Vermeire S; Van Assche G; Van Eyken P; Joossens S; Claessens G; Vlietinck R; Rutgeerts P; Geboes K
Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease.
Gut 2005;54(2):223-7.
2005: Verbeke K; de Preter V; Geboes K; Daems T; van den Mooter G; Evenepoel P; Rutgeerts P
In vivo evaluation of a colonic delivery system using isotope techniques.
Alimentary pharmacology & therapeutics 2005;21(2):187-94.
2004: Joossens Sofie; Vermeire Severine; Van Steen Kristel; Godefridis Godelieve; Claessens Greet; Pierik Marie; Vlietinck Robert; Aerts Raymond; Rutgeerts Paul; Bossuyt Xavier
Pancreatic autoantibodies in inflammatory bowel disease.
Inflammatory bowel diseases 2004;10(6):771-7.
2004: Van Meensel Britta; Hiele Martin; Hoffman Ilse; Vermeire Severine; Rutgeerts Paul; Geboes Karel; Bossuyt Xavier
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.
Clinical chemistry 2004;50(11):2125-35.
2004: Daperno Marco; D'Haens Geert; Van Assche Gert; Baert Filip; Bulois Philippe; Maunoury Vincent; Sostegni Raffaello; Rocca Rodolfo; Pera Angelo; Gevers Annemie; Mary Jean-Yves; Colombel Jean-Frédéric; Rutgeerts Paul
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
Gastrointestinal endoscopy 2004;60(4):505-12.
2004: Bennink Roelof J; Peeters Marc; Rutgeerts Paul; Mortelmans Luc
Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1698-704.
2004: Wolf Anna Maria; Wolf Dominik; Rumpold Holger; Moschen Alexander R; Kaser Arthur; Obrist Peter; Fuchs Dietmar; Brandacher Gerald; Winkler Christiane; Geboes Karel; Rutgeerts Paul; Tilg Herbert
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.
Clinical immunology (Orlando, Fla.) 2004;113(1):47-55.
2004: Rutgeerts P
Review article: treatment of perianal fistulizing Crohn's disease.
Alimentary pharmacology & therapeutics 2004;20 Suppl 4():106-10.
2004: Baert F; Vermeire S; Noman M; Van Assche G; D'Haens G; Rutgeerts P
Management of ulcerative colitis and Crohn's disease.
Acta clinica Belgica 2004;59(5):304-14.
2004: Vermeire Séverine; Van Assche Gert; Rutgeerts Paul
C-reactive protein as a marker for inflammatory bowel disease.
Inflammatory bowel diseases 2004;10(5):661-5.
2004: Hanauer Stephen B; Korelitz Burton I; Rutgeerts Paul; Peppercorn Mark A; Thisted Ronald A; Cohen Russell D; Present Daniel H
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Gastroenterology 2004;127(3):723-9.
2004: Franchimont N; Putzeys V; Collette J; Vermeire S; Rutgeerts P; De Vos M; Van Gossum A; Franchimont D; Fiasse R; Pelckmans P; Malaise M; Belaiche J; Louis E
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
Alimentary pharmacology & therapeutics 2004;20(6):607-14.
2004: Maerten Philippe; Geboes Karel; De Hertogh Gert; Shen Chong; Cadot Pascal; Bullens Dominique M A; Van Assche Gert; Penninckx Freddy; Rutgeerts Paul; Ceuppens Jan L
Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease.
Clinical immunology (Orlando, Fla.) 2004;112(3):239-46.
2004: Poelmans Johan; Feenstra Louw; Demedts Ingrid; Rutgeerts Paul; Tack Jan
The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms.
The American journal of gastroenterology 2004;99(8):1419-26.
2004: Joossens Sofie; Daperno Marco; Shums Zakera; Van Steen Kristel; Goeken James A; Trapani Claudio; Norman Gary L; Godefridis Godelieve; Claessens Greet; Pera Angelo; Pierik Marie; Vermeire Severine; Rutgeerts Paul; Bossuyt Xavier
Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis.
Clinical chemistry 2004;50(8):1422-5.
2004: Pierik M; Vermeire S; Steen K V; Joossens S; Claessens G; Vlietinck R; Rutgeerts P
Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
Alimentary pharmacology & therapeutics 2004;20(3):303-10.
2004: Hanauer Stephen B; Wagner Carrie L; Bala Mohan; Mayer Lloyd; Travers Suzanne; Diamond Robert H; Olson Allan; Bao Warren; Rutgeerts Paul
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(7):542-53.
2004: Gijsbers Klara; Van Assche Gert; Joossens Sofie; Struyf Sofie; Proost Paul; Rutgeerts Paul; Geboes Karel; Van Damme Jo
CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.
European journal of immunology 2004;34(7):1992-2000.
2004: Franchimont D; Vermeire S; El Housni H; Pierik M; Van Steen K; Gustot T; Quertinmont E; Abramowicz M; Van Gossum A; Devière J; Rutgeerts P
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
Gut 2004;53(7):987-92.
2004: Vermeire S; Rutgeerts P; Van Steen K; Joossens S; Claessens G; Pierik M; Peeters M; Vlietinck R
Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis.
Gut 2004;53(7):980-6.
2004: Shen Chong; Bullens Dominique; Kasran Ahmad; Maerten Philippe; Boon Louis; Aerts Johannes M F G; Van Assche Gert; Geboes Karel; Rutgeerts Paul; Ceuppens Jan L
Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
International immunopharmacology 2004;4(7):939-51.
2004: Van Assche Gert; Rutgeerts Paul
Medical management of postoperative recurrence in Crohn's disease.
Gastroenterology clinics of North America 2004;33(2):347-60, x.
2004: Rutgeerts Paul; Van Assche Gert; Vermeire Séverine
Optimizing anti-TNF treatment in inflammatory bowel disease.
Gastroenterology 2004;126(6):1593-610.
2004: Geboes Karen P; Bammens Bert; Luypaerts Anja; Malheiros Ramon; Buyse Johan; Evenepoel Pieter; Rutgeerts Paul; Verbeke Kristin
Validation of a new test meal for a protein digestion breath test in humans.
The Journal of nutrition 2004;134(4):806-10.
2004: Marchal L; D'Haens G; Van Assche G; Vermeire S; Noman M; Ferrante M; Hiele M; Bueno De Mesquita M; D'Hoore A; Penninckx F; Rutgeerts P
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.
Alimentary pharmacology & therapeutics 2004;19(7):749-54.
2004: Arts Joris; D'Haens Geert; Zeegers Miranda; Van Assche Gert; Hiele Martin; D'Hoore André; Penninckx Freddy; Vermeire Severine; Rutgeerts Paul
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.
Inflammatory bowel diseases 2004;10(2):73-8.
2004: Vermeire Severine; Rutgeerts Paul
Novel biological strategies in inflammatory bowel diseases.
Inflammatory bowel diseases 2004;10 Suppl 1():S44-51.
2004: Esters Nele; Pierik Marie; van Steen Kristel; Vermeire Severine; Claessens Greet; Joossens Sofie; Vlietinck Robert; Rutgeerts Paul
Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease.
The American journal of gastroenterology 2004;99(2):299-305.
2004: Sands Bruce E; Anderson Frank H; Bernstein Charles N; Chey William Y; Feagan Brian G; Fedorak Richard N; Kamm Michael A; Korzenik Joshua R; Lashner Bret A; Onken Jane E; Rachmilewitz Daniel; Rutgeerts Paul; Wild Gary; Wolf Douglas C; Marsters Paul A; Travers Suzanne B; Blank Marion A; van Deventer Sander J
Infliximab maintenance therapy for fistulizing Crohn's disease.
The New England journal of medicine 2004;350(9):876-85.
2004: Vermeire Séverine; Rutgeerts Paul
Antibody responses in Crohn's disease.
Gastroenterology 2004;126(2):601-4.
2004: Rutgeerts Paul; Feagan Brian G; Lichtenstein Gary R; Mayer Lloyd F; Schreiber Stefan; Colombel Jean Frederic; Rachmilewitz Daniel; Wolf Douglas C; Olson Allan; Bao Weihang; Hanauer Stephen B
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
Gastroenterology 2004;126(2):402-13.
2004: Maerten P; Shen C; Colpaert S; Liu Z; Bullens D A M; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens J L
Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
Clinical and experimental immunology 2004;135(2):310-7.
2004: Van Assche Gert; Geboes Karel; Rutgeerts Paul
Medical therapy for Crohn's disease strictures.
Inflammatory bowel diseases 2004;10(1):55-60.
2003: Tilg H; Vogelsang H; Ludwiczek O; Lochs H; Kaser A; Colombel J-F; Ulmer H; Rutgeerts P; Krüger S; Cortot A; D'Haens G; Harrer M; Gasche C; Wrba F; Kuhn I; Reinisch W
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis.
Gut 2003;52(12):1728-33.
2003: Van Assche Gert; D'Haens Geert; Noman Maja; Vermeire Séverine; Hiele Martin; Asnong Katrien; Arts Joris; D'Hoore Andre; Penninckx Freddy; Rutgeerts Paul
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.
Gastroenterology 2003;125(4):1025-31.
2003: Geboes K P; Luypaerts A; Rutgeerts P; Verbeke K
Inulin is an ideal substrate for a hydrogen breath test to measure the orocaecal transit time.
Alimentary pharmacology & therapeutics 2003;18(7):721-9.
2003: Nikolaus S; Rutgeerts P; Fedorak R; Steinhart A H; Wild G E; Theuer D; Möhrle J; Schreiber S
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study.
Gut 2003;52(9):1286-90.
2003: Lemahieu W P D; Maes B D; Ghoos Y; Rutgeerts P; Verbeke K; Vanrenterghem Y
Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test.
American journal of physiology. Gastrointestinal and liver physiology 2003;285(3):G470-82.
2003: Bammens Bert; Evenepoel Pieter; Rutgeerts Paul; Ghoos Yvo; Maes Bart
13C-breath tests in peritoneal dialysis patients: influence of dialysis fluids.
European journal of gastroenterology & hepatology 2003;15(8):931-2.
2003: Vermeire Severine; Noman Maja; Van Assche Gert; Baert Filip; Van Steen Kristel; Esters Nele; Joossens Sofie; Bossuyt Xavier; Rutgeerts Paul
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.
Gastroenterology 2003;125(1):32-9.
2003: Rutgeerts P; Van Deventer S; Schreiber S
Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition.
Alimentary pharmacology & therapeutics 2003;17(12):1435-50.
2003: Suenaert P; Bulteel V; Den Hond E; Geypens B; Monsuur F; Luypaerts A; Ghoos Y; Rutgeerts P
In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.
Scandinavian journal of gastroenterology 2003;38(4):399-408.
2003: Thomeer Maarten; Carbone Iacopo; Bosmans Hilde; Kiss Gabriel; Bielen Didier; Vanbeckevoort Dirk; Van Cutsem Eric; Rutgeerts Paul; Marchal Guy
Stool tagging applied in thin-slice multidetector computed tomography colonography.
Journal of computer assisted tomography 2003;27(2):132-9.
2003: Bielen Didier; Thomeer Maarten; Vanbeckevoort Dirk; Kiss Gabriel; Maes Frederik; Marchal Guy; Rutgeerts Paul
Dry preparation for virtual CT colonography with fecal tagging using water-soluble contrast medium: initial results.
European radiology 2003;13(3):453-8.
2003: Rutgeerts Paul
Strategies in the prevention of post-operative recurrence in Crohn's disease.
Best practice & research. Clinical gastroenterology 2003;17(1):63-73.
2003: Van Assche Gert; Dalle Ignace; Noman Maja; Aerden Isolde; Swijsen Caroline; Asnong Katrien; Maes Bart; Ceuppens Jan; Geboes Karel; Rutgeerts Paul
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis.
The American journal of gastroenterology 2003;98(2):369-76.
2003: Van Assche Gert; Vanbeckevoort Dirk; Bielen Didier; Coremans Georges; Aerden Isolde; Noman Maya; D'Hoore Andre; Penninckx Freddy; Marchal Guy; Cornillie Freddy; Rutgeerts Paul
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
The American journal of gastroenterology 2003;98(2):332-9.
2003: Baert Filip; Noman Maja; Vermeire Severine; Van Assche Gert; D' Haens Geert; Carbonez An; Rutgeerts Paul
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
The New England journal of medicine 2003;348(7):601-8.
2003: Rutgeerts P; Lemmens L; Van Assche G; Noman M; Borghini-Fuhrer I; Goedkoop R
Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study.
Alimentary pharmacology & therapeutics 2003;17(2):185-92.
2003: Ghosh Subrata; Goldin Eran; Gordon Fiona H; Malchow Helmut A; Rask-Madsen Jørgen; Rutgeerts Paul; Vyhnálek Petr; Zádorová Zdena; Palmer Tanya; Donoghue Stephen;
Natalizumab for active Crohn's disease.
The New England journal of medicine 2003;348(1):24-32.
2003: Rutgeerts P
Modern therapy for inflammatory bowel disease.
Scandinavian journal of gastroenterology. Supplement 2003;(237):30-3.
2002: Van Assche Gert; Baert Filip; De Reuck Marc; De Vos Martine; De Wit Olivier; Hoang Pierre; Louis Edouard; Mana Fazia; Pelckmans Paul; Rutgeerts Paul; Van Gossum Andre; D'Haens Geert
The role of aminosalicylates in the treatment of ulcerative colitis.
Acta gastro-enterologica Belgica 2002;65(4):196-9.
2002: Colpaert Stefaan; Vastraelen Kathleen; Liu Zhanju; Maerten Philippe; Shen Chong; Penninckx Freddy; Geboes Karel; Rutgeerts Paul; Ceuppens Jan L
In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
European cytokine network 2002;13(4):431-7.
2002: Ghoos Yvo; Geypens Benny; Rutgeerts Paul
Stable isotopes and 13CO2 breath tests for investigating gastrointestinal functions.
Food and nutrition bulletin 2002;23(3 Suppl):166-8.
2002: Vermeire Severine; Louis Edouard; Carbonez An; Van Assche Gert; Noman Maja; Belaiche Jacques; De Vos Martine; Van Gossum Andre; Pescatore Paul; Fiasse Rene; Pelckmans Paul; Reynaert Hendrik; D'Haens Geert; Rutgeerts Paul;
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease.
The American journal of gastroenterology 2002;97(9):2357-63.
2002: Suenaert Peter; Bulteel Veerle; Lemmens Liesbeth; Noman Maja; Geypens Benny; Van Assche Gert; Geboes Karel; Ceuppens Jan L; Rutgeerts Paul
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
The American journal of gastroenterology 2002;97(8):2000-4.
2002: Geboes K P; Maes B; Luypaerts A; Evenepoel P; Rutgeerts P; Ghoos Y; Geypens B
Magnesium chloride slows gastric emptying, but does not affect digestive functions.
Alimentary pharmacology & therapeutics 2002;16(8):1571-7.
2002: Louis E; Vermeire S; Rutgeerts P; De Vos M; Van Gossum A; Pescatore P; Fiasse R; Pelckmans P; Reynaert H; D'Haens G; Malaise M; Belaiche J
A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism.
Scandinavian journal of gastroenterology 2002;37(7):818-24.
2002: van Assche Gert; Rutgeerts Paul
Antiadhesion molecule therapy in inflammatory bowel disease.
Inflammatory bowel diseases 2002;8(4):291-300.
2002: Vermeire Severine; Louis Edouard; Rutgeerts Paul; De Vos Martine; Van Gossum Andre; Belaiche Jacques; Pescatore Paul; Fiasse Rene; Pelckmans Paul; Vlietinck Robert; Merlin Françoise; Zouali Habib; Thomas Gilles; Colombel Jean-Frederic; Hugot Jean-Pierre;
NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
Gastroenterology 2002;123(1):106-11.
2002: Esters N; Vermeire S; Joossens S; Noman M; Louis E; Belaiche J; De Vos M; Van Gossum A; Pescatore P; Fiasse R; Pelckmans P; Reynaert H; Poulain D; Bossuyt X; Rutgeerts P;
Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease.
The American journal of gastroenterology 2002;97(6):1458-62.
2002: Thomeer M; Bielen D; Vanbeckevoort D; Dymarkowski S; Gevers A; Rutgeerts P; Hiele M; Van Cutsem E; Marchal G
Patient acceptance for CT colonography: what is the real issue?
European radiology 2002;12(6):1410-5.
2002: Hanauer Stephen B; Feagan Brian G; Lichtenstein Gary R; Mayer Lloyd F; Schreiber S; Colombel Jean Frederic; Rachmilewitz Daniel; Wolf Douglas C; Olson Allan; Bao Weihang; Rutgeerts Paul;
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Lancet 2002;359(9317):1541-9.
2002: Joossens Sofie; Reinisch Walter; Vermeire Séverine; Sendid Boualem; Poulain Daniel; Peeters Marc; Geboes Karel; Bossuyt Xavier; Vandewalle Peggy; Oberhuber Georg; Vogelsang Harald; Rutgeerts Paul; Colombel Jean-Frédéric
The value of serologic markers in indeterminate colitis: a prospective follow-up study.
Gastroenterology 2002;122(5):1242-7.
2002: Gevers Anna-Maria; De Goede Eric; Simoens Marc; Hiele Martin; Rutgeerts Paul
A randomized trial comparing injection therapy with hemoclip and with injection combined with hemoclip for bleeding ulcers.
Gastrointestinal endoscopy 2002;55(4):466-9.
2002: Rutgeerts Paul
A critical assessment of new therapies in inflammatory bowel disease.
Journal of gastroenterology and hepatology 2002;17 Suppl():S176-85.
2002: Sandborn William J; Feagan Brian G; Hanauer Stephen B; Lochs Herbert; Löfberg Robert; Modigliani Robert; Present Daniel H; Rutgeerts Paul; Schölmerich Jurgen; Stange Eduard F; Sutherland Lloyd R
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
Gastroenterology 2002;122(2):512-30.
2002: Tilg H; van Montfrans C; van den Ende A; Kaser A; van Deventer S J H; Schreiber S; Gregor M; Ludwiczek O; Rutgeerts P; Gasche C; Koningsberger J C; Abreu L; Kuhn I; Cohard M; LeBeaut A; Grint P; Weiss G
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma.
Gut 2002;50(2):191-5.
2002: Baert Filip; Schmit Alain; D'Haens Geert; Dedeurwaerdere Franceska; Louis Edouard; Cabooter Marc; De Vos Martine; Fontaine Fernand; Naegels Serge; Schurmans Piet; Stals Hedwig; Geboes Karel; Rutgeerts Paul;
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up.
Gastroenterology 2002;122(1):20-5.
2002: Colpaert Stefaan; Vanstraelen Kathleen; Liu Zhanju; Penninckx Freddy; Geboes Karel; Rutgeerts Paul; Ceuppens Jan
Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease.
Clinical immunology (Orlando, Fla.) 2002;102(1):68-76.
2002: Meresse B; Rutgeerts P; Malchow H; Dubucquoi S; Dessaint J P; Cohard M; Colombel J F; Desreumaux P
Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease.
Gut 2002;50(1):25-8.
2002: Rutgeerts P
Current dilemmas in the management of inflammatory bowel disease.
The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 2002;(587):58-61.
2001: Colpaert S; Liu Z; De Greef B; Rutgeerts P; Ceuppens J L; Geboes K
Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model.
Alimentary pharmacology & therapeutics 2001;15(11):1827-36.
2001: D'Haens G; Swijsen C; Noman M; Lemmens L; Ceuppens J; Agbahiwe H; Geboes K; Rutgeerts P
Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial.
The American journal of gastroenterology 2001;96(9):2564-8.
2001: Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens J L
B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1830-8.
2001: Colombel J F; Rutgeerts P; Malchow H; Jacyna M; Nielsen O H; Rask-Madsen J; Van Deventer S; Ferguson A; Desreumaux P; Forbes A; Geboes K; Melani L; Cohard M
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease.
Gut 2001;49(1):42-6.
2001: Liu Z; Geboes K; Heremans H; Overbergh L; Mathieu C; Rutgeerts P; Ceuppens J L
Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
European journal of immunology 2001;31(5):1550-60.
2001: Rutgeerts P J
Conventional treatment of Crohn's disease: objectives and outcomes.
Inflammatory bowel diseases 2001;7 Suppl 1():S2-8.
2001: D'Haens G; Lemmens L; Geboes K; Vandeputte L; Van Acker F; Mortelmans L; Peeters M; Vermeire S; Penninckx F; Nevens F; Hiele M; Rutgeerts P
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.
Gastroenterology 2001;120(6):1323-9.
2001: Cornillie F; Shealy D; D'Haens G; Geboes K; Van Assche G; Ceuppens J; Wagner C; Schaible T; Plevy S E; Targan S R; Rutgeerts P
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.
Alimentary pharmacology & therapeutics 2001;15(4):463-73.
2001: Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
The American journal of gastroenterology 2001;96(3):730-4.
2001: Vermeire S; Satsangi J; Peeters M; Parkes M; Jewell D P; Vlietinck R; Rutgeerts P
Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome.
Gastroenterology 2001;120(4):834-40.
2001: Vermeire S; Joossens S; Peeters M; Monsuur F; Marien G; Bossuyt X; Groenen P; Vlietinck R; Rutgeerts P
Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.
Gastroenterology 2001;120(4):827-33.
2001: Simoens M; Rutgeerts P
Non-variceal upper gastrointestinal bleeding.
Best practice & research. Clinical gastroenterology 2001;15(1):121-33.
2001: Vermeire S; Peeters M; Vlietinck R; Joossens S; Den Hond E; Bulteel V; Bossuyt X; Geypens B; Rutgeerts P
Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.
Inflammatory bowel diseases 2001;7(1):8-15.
2001: Rutgeerts P
The use of budesonide in the treatment of active Crohn's disease is good clinical practice.
Inflammatory bowel diseases 2001;7(1):60-61; discussion 62-3.
2001: Bennink R; Peeters M; D'Haens G; Rutgeerts P; Mortelmans L
Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extent and severity of an acute exacerbation of ulcerative colitis.
Clinical nuclear medicine 2001;26(2):99-104.
2001: Rutgeerts P; Geboes K
Understanding inflammatory bowel disease--the clinician's perspective.
The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 2001;(586):66-72.
2000: Rutgeerts P; Vermeire S
Serological diagnosis of inflammatory bowel disease.
Lancet 2000;356(9248):2117-8.
2000: Fedorak R N; Gangl A; Elson C O; Rutgeerts P; Schreiber S; Wild G; Hanauer S B; Kilian A; Cohard M; LeBeaut A; Feagan B
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.
Gastroenterology 2000;119(6):1473-82.
2000: Schreiber S; Fedorak R N; Nielsen O H; Wild G; Williams C N; Nikolaus S; Jacyna M; Lashner B A; Gangl A; Rutgeerts P; Isaacs K; van Deventer S J; Koningsberger J C; Cohard M; LeBeaut A; Hanauer S B
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.
Gastroenterology 2000;119(6):1461-72.
2000: Baert F J; Rutgeerts P J
Medical therapies for ulcerative colitis and Crohn's disease.
Current gastroenterology reports 2000;2(6):446-50.
2000: Ghoos Y; Geypens B; Rutgeerts P
13CO2 breath tests and stable isotopes for investigating gastrointestinal functions.
Acta gastro-enterologica Belgica 2000;63(4):325-7.
2000: Rutgeerts P
Management of perianal Crohn's disease.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2000;14 Suppl C():7C-12C.
2000: Vermeire S; Peeters M; Vlietinck R; Parkes M; Satsangi J; Jewell D; Rutgeerts P
Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity.
Inflammatory bowel diseases 2000;6(3):165-70.
2000: Hiele M; Rutgeerts P
Combination therapies for the endoscopic treatment of gastrointestinal bleeding.
Baillière's best practice & research. Clinical gastroenterology 2000;14(3):459-66.
2000: Suenaert P; Bulteel V; Den Hond E; Hiele M; Peeters M; Monsuur F; Ghoos Y; Rutgeerts P
The effects of smoking and indomethacin on small intestinal permeability.
Alimentary pharmacology & therapeutics 2000;14(6):819-22.
2000: Liu Z; Geboes K; Colpaert S; Overbergh L; Mathieu C; Heremans H; de Boer M; Boon L; D'Haens G; Rutgeerts P; Ceuppens J L
Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(11):6005-14.
2000: Rutgeerts P
Infliximab is the drug we have been waiting for in Crohn's disease.
Inflammatory bowel diseases 2000;6(2):132-6.
2000: Gevers A M; Macken E; Hiele M; Rutgeerts P
Endoscopic laser therapy for palliation of patients with distal colorectal carcinoma: analysis of factors influencing long-term outcome.
Gastrointestinal endoscopy 2000;51(5):580-5.
2000: Liu Z; Geboes K; Colpaert S; D'Haens G R; Rutgeerts P; Ceuppens J L
IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(7):3608-15.
2000: Craninx M; D'Haens G; Cokelaere K; Baert F; Penninckx F; D'Hoore A; Ectors N; Rutgeerts P; Geboes K
Crohn's disease and intestinal endometriosis: an intriguing co-existence.
European journal of gastroenterology & hepatology 2000;12(2):217-21.
2000: Vermeire S; Peeters M; Rutgeerts P
Diagnostic approach to IBD.
Hepato-gastroenterology 2000;47(31):44-8.
2000: Louis E; Peeters M; Franchimont D; Seidel L; Fontaine F; Demolin G; Croes F; Dupont P; Davin L; Omri S; Rutgeerts P; Belaiche J
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?
Clinical and experimental immunology 2000;119(1):64-8.
2000: Evenepoel P; Hiele M; Geypens B; Geboes K P; Rutgeerts P; Ghoos Y
13C-egg white breath test: a non-invasive test of pancreatic trypsin activity in the small intestine.
Gut 2000;46(1):52-7.
1999: Bennink R; Peeters M; Van den Maegdenbergh V; Geypens B; Rutgeerts P; De Roo M; Mortelmans L
Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women.
European journal of nuclear medicine 1999;26(12):1560-6.
1999: Maes B D; Vanwalleghem J; Kuypers D; Ghoos Y; Rutgeerts P J; Vanrenterghem Y F
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine.
Transplantation 1999;68(10):1482-5.
1999: D'Haens G; Rutgeerts P
Postoperative recurrence of Crohn's disease: pathophysiology and prevention.
Inflammatory bowel diseases 1999;5(4):295-303.
1999: Evenepoel P; Claus D; Geypens B; Hiele M; Geboes K; Rutgeerts P; Ghoos Y
Amount and fate of egg protein escaping assimilation in the small intestine of humans.
The American journal of physiology 1999;277(5 Pt 1):G935-43.
1999: D'Haens G; Geboes K; Rutgeerts P
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine.
Gastrointestinal endoscopy 1999;50(5):667-71.
1999: Geboes K; Desreumaux P; Jouret A; Ectors N; Rutgeerts P; Colombel J F
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores]
Gastroentérologie clinique et biologique 1999;23(10):1062-73.
1999: Rutgeerts P; Baert F
New strategies in the management of inflammatory bowel disease.
Acta clinica Belgica 1999;54(5):274-80.
1999: Geboes K; Rutgeerts P
Dysplasia in inflammatory bowel diseases: definition and clinical impact.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 1999;13(8):671-8.
1999: Rutgeerts P; D'Haens G; Targan S; Vasiliauskas E; Hanauer S B; Present D H; Mayer L; Van Hogezand R A; Braakman T; DeWoody K L; Schaible T F; Van Deventer S J
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Gastroenterology 1999;117(4):761-9.
1999: Liu Z; Colpaert S; D'Haens G R; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens J L
Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(7):4049-57.
1999: Rutgeerts P J
Review article: efficacy of infliximab in Crohn's disease--induction and maintenance of remission.
Alimentary pharmacology & therapeutics 1999;13 Suppl 4():9-15; discussion 38.
1999: Rutgeerts P J; Targan S R
Introduction: anti-TNF strategies in the treatment of Crohn's disease.
Alimentary pharmacology & therapeutics 1999;13 Suppl 4():1.
1999: Geypens B; Bennink R; Peeters M; Evenepoel P; Mortelmans L; Maes B; Ghoos Y; Rutgeerts P
Validation of the lactose-[13C]ureide breath test for determination of orocecal transit time by scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(9):1451-5.
1999: Hond E D; Peeters M; Hiele M; Bulteel V; Ghoos Y; Rutgeerts P
Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans.
Alimentary pharmacology & therapeutics 1999;13(5):679-85.
1999: Present D H; Rutgeerts P; Targan S; Hanauer S B; Mayer L; van Hogezand R A; Podolsky D K; Sands B E; Braakman T; DeWoody K L; Schaible T F; van Deventer S J
Infliximab for the treatment of fistulas in patients with Crohn's disease.
The New England journal of medicine 1999;340(18):1398-405.
1999: D'haens G; Van Deventer S; Van Hogezand R; Chalmers D; Kothe C; Baert F; Braakman T; Schaible T; Geboes K; Rutgeerts P
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.
Gastroenterology 1999;116(5):1029-34.
1999: Simoens M; Gevers A M; Rutgeerts P
Endoscopic therapy for upper gastrointestinal hemorrhage: a state of the art.
Hepato-gastroenterology 1999;46(26):737-45.
1999: Maes B D; Spitz B; Ghoos Y F; Hiele M I; Evenepoel P; Rutgeerts P J
Gastric emptying in hyperemesis gravidarum and non-dyspeptic pregnancy.
Alimentary pharmacology & therapeutics 1999;13(2):237-43.
1999: Vandeputte L; D'Haens G; Baert F; Rutgeerts P
Methotrexate in refractory Crohn's disease.
Inflammatory bowel diseases 1999;5(1):11-5.
1999: Den Hond E; Hiele M; Peeters M; Ghoos Y; Rutgeerts P
Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease.
JPEN. Journal of parenteral and enteral nutrition 1999;23(1):7-11.
1999: Baert F J; D'Haens G R; Peeters M; Hiele M I; Schaible T F; Shealy D; Geboes K; Rutgeerts P J
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
Gastroenterology 1999;116(1):22-8.
1998: Rutgeerts P; Baert F
Immunosuppressive drugs in the treatment of Crohn's disease.
The European journal of surgery = Acta chirurgica 1998;164(12):911-5.
1998: Evenepoel P; Claus D; Geypens B; Maes B; Hiele M; Rutgeerts P; Ghoos Y
Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy.
Alimentary pharmacology & therapeutics 1998;12(10):1011-9.
1998: Gevers A M; Macken E; Hiele M; Rutgeerts P
A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula.
Gastrointestinal endoscopy 1998;48(4):383-8.
1998: Evenepoel P; Geypens B; Luypaerts A; Hiele M; Ghoos Y; Rutgeerts P
Digestibility of cooked and raw egg protein in humans as assessed by stable isotope techniques.
The Journal of nutrition 1998;128(10):1716-22.
1998: Tack J; Gevers A M; Rutgeerts P
Self-expandable metallic stents in the palliation of rectosigmoidal carcinoma: a follow-up study.
Gastrointestinal endoscopy 1998;48(3):267-71.
1998: Bennink R; Peeters M; Van den Maegdenbergh V; Geypens B; Rutgeerts P; De Roo M; Mortelmans L
Comparison of total and compartmental gastric emptying and antral motility between healthy men and women.
European journal of nuclear medicine 1998;25(9):1293-9.
1998: Den Hond E; Hiele M; Evenepoel P; Peeters M; Ghoos Y; Rutgeerts P
In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis.
Gastroenterology 1998;115(3):584-90.
1998: Maes B D; Mys G; Geypens B J; Evenepoel P; Ghoos Y F; Rutgeerts P J
Gastric emptying flow curves separated from carbon-labeled octanoic acid breath test results.
The American journal of physiology 1998;275(1 Pt 1):G169-75.
1998: D'Haens G; Verstraete A; Cheyns K; Aerden I; Bouillon R; Rutgeerts P
Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease.
Alimentary pharmacology & therapeutics 1998;12(5):419-24.
1998: Evenepoel P; Geypens B; Rutgeerts P; Ghoos Y
Study of protein assimilation, using stable isotope techniques.
Revista de medicina de la Universidad de Navarra 1998;42(2):104-8.
1998: Maes B D; Hiele M I; Geypens B J; Ghoos Y F; Rutgeerts P J
Gastric emptying of the liquid, solid and oil phase of a meal in normal volunteers and patients with Billroth II gastrojejunostomy.
European journal of clinical investigation 1998;28(3):197-204.
1998: D'Haens G; Suenaert P; Westhovens R; Rutgeerts P
Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine.
Inflammatory bowel diseases 1998;4(1):27-8.
1998: D'Haens G R; Geboes K; Peeters M; Baert F; Penninckx F; Rutgeerts P
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.
Gastroenterology 1998;114(2):262-7.
1998: Macken E; Gevers A M; Hendrickx A; Rutgeerts P
Midazolam versus diazepam in lipid emulsion as conscious sedation for colonoscopy with or without reversal of sedation with flumazenil.
Gastrointestinal endoscopy 1998;47(1):57-61.
1998: Rutgeerts P
The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
Mediators of inflammation 1998;7(3):137-40.
1998: Vermeire S; Rutgeerts P
[Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection]
Zentralblatt für Chirurgie 1998;123(4):352-6.
1997: Targan S R; Hanauer S B; van Deventer S J; Mayer L; Present D H; Braakman T; DeWoody K L; Schaible T F; Rutgeerts P J
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
The New England journal of medicine 1997;337(15):1029-35.
1997: Rutgeerts P; Rauws E; Wara P; Swain P; Hoos A; Solleder E; Halttunen J; Dobrilla G; Richter G; Prassler R
Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer.
Lancet 1997;350(9079):692-6.
1997: Peeters M; Geypens B; Claus D; Nevens H; Ghoos Y; Verbeke G; Baert F; Vermeire S; Vlietinck R; Rutgeerts P
Clustering of increased small intestinal permeability in families with Crohn's disease.
Gastroenterology 1997;113(3):802-7.
1997: D'Haens G; Geboes K; Peeters M; Baert F; Ectors N; Rutgeerts P
Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study.
The American journal of gastroenterology 1997;92(8):1275-9.
1997: Van Gossum A; Schmit A; Adler M; Chioccioli C; Fiasse R; Louwagie P; D'Haens G; Rutgeerts P; De Vos M; Reynaert H; Devis G; Belaiche J; Van Outryve M
Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group.
Acta gastro-enterologica Belgica 1997;60(3):197-200.
1997: Geypens B; Claus D; Evenepoel P; Hiele M; Maes B; Peeters M; Rutgeerts P; Ghoos Y
Influence of dietary protein supplements on the formation of bacterial metabolites in the colon.
Gut 1997;41(1):70-6.
1997: Maes B D; Ghoos Y F; Hiele M I; Rutgeerts P J
Gastric emptying rate of solids in patients with nonulcer dyspepsia.
Digestive diseases and sciences 1997;42(6):1158-62.
1997: Hiele M; De Leyn P; Schurmans P; Lerut A; Huys S; Geboes K; Gevers A M; Rutgeerts P
Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction.
Gastrointestinal endoscopy 1997;45(5):381-6.
1997: D'Haens G; Geboes K; Ponette E; Penninckx F; Rutgeerts P
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease.
Gastroenterology 1997;112(5):1475-81.
1997: Evenepoel P; Hiele M; Luypaerts A; Geypens B; Buyse J; Decuypere E; Rutgeerts P; Ghoos Y
Production of egg proteins, enriched with L-leucine-13C1, for the study of protein assimilation in humans using the breath test technique.
The Journal of nutrition 1997;127(2):327-31.
1997: Baert F; Rutgeerts P
Immunomodulator therapy of inflammatory bowel disease.
Acta clinica Belgica 1997;52(5):251-7.
1996: Wilmer A; Rutgeerts P
Push enteroscopy. Technique, depth, and yield of insertion.
Gastrointestinal endoscopy clinics of North America 1996;6(4):759-76.
1996: Macken E; Gevers A; Hiele M; Rutgeerts P
Treatment of esophagorespiratory fistulas with a polyurethane-covered self-expanding metallic mesh stent.
Gastrointestinal endoscopy 1996;44(3):324-6.
1996: Peeters M; Nevens H; Baert F; Hiele M; de Meyer A M; Vlietinck R; Rutgeerts P
Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics.
Gastroenterology 1996;111(3):597-603.
1996: Löfberg R; Rutgeerts P; Malchow H; Lamers C; Danielsson A; Olaison G; Jewell D; Ostergaard Thomsen O; Lorenz-Meyer H; Goebell H; Hodgson H; Persson T; Seidegård C
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.
Gut 1996;39(1):82-6.
1996: Perri F; Ghoos Y F; Maes B D; Geypens B J; Ectors N; Geboes K; Hiele M I; Rutgeerts P J
Gastric emptying and Helicobacter pylori infection in duodenal ulcer disease.
Digestive diseases and sciences 1996;41(3):462-8.
1996: Maes B D; Ghoos Y F; Geypens B J; Hiele M I; Rutgeerts P J
Relation between gastric emptying rate and rate of intraluminal lipolysis.
Gut 1996;38(1):23-7.
1995: Perri F; Maes B; Geypens B; Ghoos Y; Hiele M; Rutgeerts P
The influence of isolated doses of drugs, feeding and colonic bacterial ureolysis on urea breath test results.
Alimentary pharmacology & therapeutics 1995;9(6):705-9.
1995: Nevens F; Broeckaert L; Rutgeerts P; Van Steenbergen W; Fevery J
The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.
Hepato-gastroenterology 1995;42(6):979-84.
1995: Van Cutsem E; Tejpar S; Rutgeerts P; Janssens J
Screening for colorectal cancer.
Acta gastro-enterologica Belgica 1995;58(5-6):397-404.
1995: Rutgeerts P; Hiele M; Geboes K; Peeters M; Penninckx F; Aerts R; Kerremans R
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.
Gastroenterology 1995;108(6):1617-21.
1995: Geboes K; Rutgeerts P
CD44v6 and CD44v3 variants in inflammatory bowel disease.
Lancet 1995;345(8959):1191-2.
1995: Couckuyt H; Gevers A M; Coremans G; Hiele M; Rutgeerts P
Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's strictures: a prospective longterm analysis.
Gut 1995;36(4):577-80.
1995: Maes B D; Ghoos Y F; Geypens B J; Hiele M I; Rutgeerts P J
Relation between gastric emptying rate and energy intake in children compared with adults.
Gut 1995;36(2):183-8.
1995: Maes B D; Ghoos Y F; Geypens B J; Hiele M I; Rutgeerts P J
Influence of octreotide on the gastric emptying of solids and liquids in normal healthy subjects.
Alimentary pharmacology & therapeutics 1995;9(1):11-8.
1995: Peetermans W E; D'Haens G R; Ceuppens J L; Rutgeerts P; Geboes K
Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease.
Gastroenterology 1995;108(1):75-82.
1994: Maes B D; Ghoos Y F; Rutgeerts P J; Hiele M I; Geypens B; Vantrappen G
[*C]octanoic acid breath test to measure gastric emptying rate of solids.
Digestive diseases and sciences 1994;39(12 Suppl):104S-106S.
1994: Vergote G; Ponette E; Verschakelen J; Baert A L; Rutgeerts P; Moerman P
Esophageal metastasis from breast carcinoma.
Journal belge de radiologie 1994;77(6):268-9.
1994: D'Haens G; Hiele M; Rutgeerts P; Geboes K; Ceuppens J L
Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.
Gut 1994;35(12):1728-33.
1994: Peeters M; Hiele M; Ghoos Y; Huysmans V; Geboes K; Vantrappen G; Rutgeerts P
Test conditions greatly influence permeation of water soluble molecules through the intestinal mucosa: need for standardisation.
Gut 1994;35(10):1404-8.
1994: Peeters M; Ghoos Y; Maes B; Hiele M; Geboes K; Vantrappen G; Rutgeerts P
Increased permeability of macroscopically normal small bowel in Crohn's disease.
Digestive diseases and sciences 1994;39(10):2170-6.
1994: Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen O O; Lorenz-Meyer H
A comparison of budesonide with prednisolone for active Crohn's disease.
The New England journal of medicine 1994;331(13):842-5.
1994: Gevers A M; Couckuyt H; Coremans G; Hiele M; Rutgeerts P
Efficacy and safety of hydrostatic balloon dilation of ileocolonic Crohn's strictures. A prospective long-term analysis.
Acta gastro-enterologica Belgica 1994;57(5-6):320-2.
1994: D'Haens G R; Rutgeerts P J
Postoperative recurrence of Crohn's disease: pathogenesis and prevention.
Acta gastro-enterologica Belgica 1994;57(5-6):311-3.
1994: Rutgeerts P
Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
The Netherlands journal of medicine 1994;45(2):60-4.
1994: Maes B D; Ghoos Y F; Geypens B J; Mys G; Hiele M I; Rutgeerts P J; Vantrappen G
Combined carbon-13-glycine/carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(5):824-31.
1994: Rutgeerts P; D'Haens G; Hiele M; Geboes K; Vantrappen G
Appendectomy protects against ulcerative colitis.
Gastroenterology 1994;106(5):1251-3.
1994: Heyvaert G; Penninckx F; Filez L; Aerts R; Kerremans R; Rutgeerts P
Restorative proctocolectomy in elective and emergency cases of ulcerative colitis.
International journal of colorectal disease 1994;9(2):73-6.
1994: D'Haens G; Rutgeerts P; Geboes K; Vantrappen G
The natural history of esophageal Crohn's disease: three patterns of evolution.
Gastrointestinal endoscopy 1994;40(3):296-300.
1994: Ectors N L; Geboes K J; De Vos R M; Heidbuchel H P; Rutgeerts P J; Desmet V J; Vantrappen G R
Whipple's disease: a histological, immunocytochemical, and electron microscopic study of the small intestinal epithelium.
The Journal of pathology 1994;172(1):73-9.
1993: D'Haens G; Breysem Y; Rutgeerts P; van Besien B; Geboes K; Ponette E; Vantrappen G
Proctitis and rectal stenosis induced by nonsteroidal antiinflammatory suppositories.
Journal of clinical gastroenterology 1993;17(3):207-12.
1993: Ectors N L; Dixon M F; Geboes K J; Rutgeerts P J; Desmet V J; Vantrappen G R
Granulomatous gastritis: a morphological and diagnostic approach.
Histopathology 1993;23(1):55-61.
1993: Ghoos Y F; Maes B D; Geypens B J; Mys G; Hiele M I; Rutgeerts P J; Vantrappen G
Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.
Gastroenterology 1993;104(6):1640-7.
1993: Rutgeerts P; Geboes K
Crohn's disease and pre-aphthoid lesions.
Lancet 1993;341(8858):1443-4.
1993: Rutgeerts P; Gevers A M; Hiele M; Broeckaert L; Vantrappen G
Endoscopic injection therapy to prevent rebleeding from peptic ulcers with a protruding vessel: a controlled comparative trial.
Gut 1993;34(3):348-50.
1992: Rutgeerts P; Peeters M; Geboes K; Vantrappen G
Infectious agents in inflammatory bowel disease.
Endoscopy 1992;24(6):565-7.
1992: Geboes K; Rutgeerts P; Ectors N; Mebis J; Penninckx F; Vantrappen G; Desmet V J
Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease.
Gastroenterology 1992;103(2):439-47.
1992: Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G
Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.
Digestive diseases and sciences 1992;37(7):1057-64.
1992: Ectors N; Geboes K; De Vos R; Heidbuchel H; Rutgeerts P; Desmet V; Vantrappen G
Whipple's disease: a histological, immunocytochemical and electronmicroscopic study of the immune response in the small intestinal mucosa.
Histopathology 1992;21(1):1-12.
1992: Rutgeerts P; Geboes K; Vantrappen G; Van Isveldt J; Peeters M; Penninckx F; Hiele M
Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum.
Journal of clinical gastroenterology 1992;15(1):24-8.
1992: Breysem Y; Janssens J F; Coremans G; Vantrappen G; Hendrickx G; Rutgeerts P
Endoscopic balloon dilation of colonic and ileo-colonic Crohn's strictures: long-term results.
Gastrointestinal endoscopy 1992;38(2):142-7.
1992: Geboes K; Ectors N; Heidbuchel H; Rutgeerts P; Desmet V; Vantrappen G
Whipple's disease: the value of upper gastrointestinal endoscopy for the diagnosis and follow-up.
Acta gastro-enterologica Belgica 1992;55(2):209-19.
1991: Rutgeerts P; Vantrappen G; Hiele M; Ghoos Y; Onkelinx C
Effects on bowel motility of misoprostol administered before and after meals.
Alimentary pharmacology & therapeutics 1991;5(5):533-42.
1991: Rutgeerts P; Goboes K; Peeters M; Hiele M; Penninckx F; Aerts R; Kerremans R; Vantrappen G
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.
Lancet 1991;338(8770):771-4.
1991: Rutgeerts P; Vantrappen G
[Gastroduodenal hemorrhage: endoscopic treatment]
Helvetica chirurgica acta 1991;58(1-2):7-19.
1991: Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G; Schoorens D
Influence of nutritional substrates on the formation of volatiles by the fecal flora.
Gastroenterology 1991;100(6):1597-602.
1991: Vanmoerkerke I; Rutgeerts P; Vantrappen G
The role of laser therapy in the palliative treatment of esophageal cancer.
Journal belge de radiologie 1991;74(5):401-6.
1990: Rutgeerts P; Geboes K; Vantrappen G; Beyls J; Kerremans R; Hiele M
Predictability of the postoperative course of Crohn's disease.
Gastroenterology 1990;99(4):956-63.
1990: Geboes K; Ectors N; Heidbuchel H; Rutgeerts P; Desmet V; Vantrappen G
Whipple's disease: endoscopic aspects before and after therapy.
Gastrointestinal endoscopy 1990;36(3):247-52.
1990: van Cutsem E; Rutgeerts P; Vantrappen G
Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone.
Lancet 1990;335(8695):953-5.
1990: Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G; de Buyser K
13CO2 breath test to measure the hydrolysis of various starch formulations in healthy subjects.
Gut 1990;31(2):175-8.
1989: Rutgeerts P; Geboes K; Vantrappen G
Experimental studies of injection therapy for severe nonvariceal bleeding in dogs.
Gastroenterology 1989;97(3):610-21.
1989: Rutgeerts P; Vantrappen G; Broeckaert L; Coremans G; Janssens J; Hiele M
Comparison of endoscopic polidocanol injection and YAG laser therapy for bleeding peptic ulcers.
Lancet 1989;1(8648):1164-7.
1989: Demaerel P; Ponette E; Lacquet F; Verbist L; Rutgeerts P; Baert A L
The role of radiology in Campylobacter enterocolitis.
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1989;150(5):551-5.
1989: Rutgeerts P
Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
Alimentary pharmacology & therapeutics 1989;3(2):183-91.
1989: Vantrappen G R; Rutgeerts P J; Ghoos Y F; Hiele M I
Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum.
Gastroenterology 1989;96(4):1126-34.
1989: Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G
Starch digestion in normal subjects and patients with pancreatic disease, using a 13CO2 breath test.
Gastroenterology 1989;96(2 Pt 1):503-9.
1988: Van Cutsem E; Rutgeerts P; Geboes K; Van Gompel F; Vantrappen G
Estrogen-progesterone treatment of Osler-Weber-Rendu disease.
Journal of clinical gastroenterology 1988;10(6):676-9.
1988: Van Hootegem P; Van Besien K; Broeckaert L; Rutgeerts P; Fevery J
Endoscopic sclerotherapy of esophageal varices. Long-term follow-up, recurrence, and survival.
Journal of clinical gastroenterology 1988;10(4):368-72.
1988: Dequeker J; Grillet B; De Clerck L; Rutgeerts P; Geboes K
Ileocolonoscopy and spondarthritis.
British journal of rheumatology 1988;27(3):246-7.
1988: Geboes K; Rutgeerts P; Penninckx F; Desmet V; Vantrappen G
Changes in small intestinal epithelial expression of MHC class II antigen after terminal ileal resection for Crohn's disease.
International journal of colorectal disease 1988;3(2):102-8.
1988: Rutgeerts P; Vantrappen G; D'Heygere F; Broeckaert L
Transendoscopic Doppler ultrasound: usefulness for diagnosis and treatment of vascular malformations.
Endoscopy 1988;20(3):99-101.
1988: Ghoos Y; Rutgeerts P; Vantrappen G; Hiele M; Schurmans P
The effect of long-term fibre and starch intake by man on faecal bile acid excretion.
European journal of clinical investigation 1988;18(2):128-32.
1988: Rutgeerts P; Vantrappen G; Broeckaert L; Muls M; Geboes K; Coremans G; Janssens J
Palliative Nd:YAG laser therapy for cancer of the esophagus and gastroesophageal junction: impact on the quality of remaining life.
Gastrointestinal endoscopy 1988;34(2):87-90.
1988: Geboes K; De Jaeger E; Rutgeerts P; Vantrappen G
Symptomatic gastrointestinal metastases from malignant melanoma. A clinical study.
Journal of clinical gastroenterology 1988;10(1):64-70.
1987: Rutgeerts P; Ghoos Y; Vantrappen G
Effects of partial ileocolectomy and Crohn's disease on biliary lipid secretion.
Digestive diseases and sciences 1987;32(11):1231-8.
1987: Grillet B; de Clerck L; Dequeker J; Rutgeerts P; Geboes K
Systematic ileocolonoscopy and bowel biopsy study in spondylarthropathy.
British journal of rheumatology 1987;26(5):338-40.
1987: Rutgeerts P; Vantrappen G; Van Hootegem P; Broeckaert L; Janssens J; Coremans G; Geboes K
Neodymium-YAG laser photocoagulation versus multipolar electrocoagulation for the treatment of severely bleeding ulcers: a randomized comparison.
Gastrointestinal endoscopy 1987;33(3):199-202.
1985: Rutgeerts P; Van Gompel F; Geboes K; Vantrappen G; Broeckaert L; Coremans G
Long term results of treatment of vascular malformations of the gastrointestinal tract by neodymium Yag laser photocoagulation.
Gut 1985;26(6):586-93.
1984: Van Hootegem P; Rutgeerts P; Fevery J; Broeckaert L; de Groote J; Vantrappen G
Sclerotherapy of oesophageal varices after variceal haemorrhage.
Endoscopy 1984;16(3):95-7.
1984: Rutgeerts P; Vantrappen G; Broeckaert L; Coremans G; Janssens J; Geboes K
A new and effective technique of Yag laser photocoagulation for severe upper gastrointestinal bleeding.
Endoscopy 1984;16(3):115-7.
1982: Rutgeerts P; Vantrappen G; Broeckaert L; Janssens J; Coremans G; Geboes K; Schurmans P
Controlled trial of YAG laser treatment of upper digestive hemorrhage.
Gastroenterology 1982;83(2):410-6.
1981: Rutgeerts P; Hendrickx H; Geboes K; Ponette E; Broeckaert L; Vantrappen G
Involvement of the upper digestive tract by systemic neurofibromatosis.
Gastrointestinal endoscopy 1981;27(1):22-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Paul Rutgeerts

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Procedures

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Paul Rutgeerts (preview)

All Publications